As of 2024-12-15, the Relative Valuation of Swedish Orphan Biovitrum AB (publ) (SOBI.ST) is 225.04 SEK. This relative valuation is based on P/E multiples. With the latest stock price at 315.20 SEK, the upside of Swedish Orphan Biovitrum AB (publ) based on Relative Valuation is -28.6%.
The range of the Relative Valuation is 136.37 - 313.01 SEK.
| Range | Selected | |
| Trailing P/E multiples | 23.2x - 31.7x | 27.8x |
| Forward P/E multiples | 17.4x - 31.1x | 22.4x |
| Fair Price | 136.37 - 313.01 | 225.04 |
| Upside | -56.7% - -0.7% | -28.6% |
| Date | P/E |
| 2024-12-13 | 31.94 |
| 2024-12-12 | 32.04 |
| 2024-12-11 | 32.12 |
| 2024-12-10 | 31.86 |
| 2024-12-09 | 31.96 |
| 2024-12-06 | 31.96 |
| 2024-12-05 | 31.33 |
| 2024-12-04 | 31.33 |
| 2024-12-03 | 30.83 |
| 2024-12-02 | 30.95 |
| 2024-11-29 | 30.64 |
| 2024-11-28 | 30.99 |
| 2024-11-27 | 31.19 |
| 2024-11-26 | 30.52 |
| 2024-11-25 | 30.26 |
| 2024-11-22 | 29.39 |
| 2024-11-21 | 29.45 |
| 2024-11-20 | 29.37 |
| 2024-11-19 | 30.60 |
| 2024-11-18 | 30.42 |
| 2024-11-15 | 30.22 |
| 2024-11-14 | 33.62 |
| 2024-11-13 | 32.96 |
| 2024-11-12 | 32.61 |
| 2024-11-11 | 33.26 |
| 2024-11-08 | 32.98 |
| 2024-11-07 | 32.81 |
| 2024-11-06 | 32.96 |
| 2024-11-05 | 33.06 |
| 2024-11-04 | 33.97 |
| 2024-11-01 | 33.38 |
| 2024-10-31 | 33.75 |
| 2024-10-30 | 34.54 |
| 2024-10-29 | 35.02 |
| 2024-10-28 | 34.96 |
| 2024-10-25 | 35.10 |
| 2024-10-24 | 34.15 |
| 2024-10-23 | 32.98 |
| 2024-10-22 | 32.35 |
| 2024-10-21 | 32.23 |
| 2024-10-18 | 32.31 |
| 2024-10-17 | 30.62 |
| 2024-10-16 | 30.08 |
| 2024-10-15 | 30.02 |
| 2024-10-14 | 30.02 |
| 2024-10-11 | 30.00 |
| 2024-10-10 | 30.04 |
| 2024-10-09 | 30.34 |
| 2024-10-08 | 30.18 |
| 2024-10-07 | 30.87 |